Effective elimination of Fn and inhibition of KIR2DL1 expression on CD8+ T cells may prolong the survival of ESCC patients, which is very important in the clinical treatment of ESCC and has broad application prospects. Here, FN1 is linked to esophageal squamous cell carcinoma.